Ravi is an Investment Director responsible for evaluating and executing transactions, as well as supporting the origination of investment opportunities. Ravi worked on our investment in Auxadi, MYCOM OSI and SteriPack.
Prior to joining Inflexion in 2018, Ravi spent four years at Rothschild working within the Healthcare M&A team. He completed a number of high-profile transactions in both pharmaceuticals and healthcare services, including the sale of Oasis Dental Care to BUPA and the acquisition of Compeed by HRA Pharma.
Outside work, Ravi is a sports enthusiast and enjoys spending his free time watching and playing a variety of sports (particularly football and tennis). Ravi is also a keen traveller and likes to visit new places and discover new cuisines.
Ravi has a degree in Economics from Cambridge University.